Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Open Access Highly Access

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy

Pascale Nicaise Roland*, Sabine Grootenboer Mignot, Alessandra Bruns, Margarita Hurtado, Elisabeth Palazzo, Gilles Hayem, Philippe Dieudé, Olivier Meyer and Sylvie Chollet Martin

Arthritis Research & Therapy 2008, 10:R142 doi:10.1186/ar2570

Accesses  

  • Last 30 days: 125 accesses
  • Last year: 1409 accesses
  • All time: 6409 accesses

Cited by

BioMed Central: 3 citations

Research article   Open Access

B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

Diego Catalán, Octavio Aravena, Francisca Sabugo, Pamela Wurmann, Lilian Soto, Alexis M Kalergis, Miguel Cuchacovich, Juan C Aguillón, Arthritis Research & Therapy 2010, 12:R68 (15 April 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review   Free

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis

Ger JM Pruijn, Allan Wiik, Walther J van Venrooij Arthritis Research & Therapy 2010, 12:203 (15 February 2010)

Abstract | Full text | PDF | PubMed

Research article   Open Access Highly Accessed

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes

Vincent Goëb, Marlène Thomas-L'Otellier, Romain Daveau, Roland Charlionet, Patrice Fardellone, Xavier Le Loët, François Tron, Danièle Gilbert, Olivier Vittecoq Arthritis Research & Therapy 2009, 11:R38 (10 March 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations